Publication | Closed Access

Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma

Lymphoid NeoplasiaRadiation OncologyCell TherapyTransplantationMarrow TransplantationMantle Cell LymphomaMedicineMalignant Blood DisorderImmunologyHematologyHigh-dose TherapyImmunotherapyOncologyCell TransplantationAutologous Stem-cell TransplantationTumor MicroenvironmentHealth Sciences